Polycarcin V induces DNA-damage response and enables the profiling of DNA-binding proteins. Issue 11 (11th March 2022)

• Record Type: Journal Article
• Authors: Yue, Zongwei; Wu, Fan; Guo, Fusheng; Park, Jiyeong; Wang, Jin; Zhang, Liyun; Liao, Daohong; Li, Wenyang; Schärer, Orlando D; Lei, Xiaoguang
• Is Part Of: National science review. Volume 9:Issue 11(2022)
• Publication Date: 2022-03-11
• Subjects: polycarcin V -- [2+2] DNA photoadduct -- light-activatable chemical probe -- ABPP for DNA-binding protein proteomics -- psoriasis treatment; Science -- Periodicals; 505
• DOI: 10.1093/nsr/nwac046
• Languages: English
• ISSNs: 2095-5138

Abstract

Abstract: To maintain genomic integrity and avoid diseases, the DNA-damage response (DDR) not only detects and repairs DNA lesions, but also contributes to the resistance to DNA-damaging chemotherapeutics. Targeting the DDR plays a significant role in drug discovery using the principle of synthetic lethality. The incomplete current knowledge of the DDR encouraged us to develop new strategies to identify and study its components and pathways. Polycarcin V, belonging to the C-aryl glycoside natural products, is a light-activatable DNA-intercalating agent that causes DNA damage by forming a covalent [2+2] cycloadduct with thymine residue under 365–450 nm of light irradiation in a DNA-sequence-independent manner. Taking advantage of the light-activatable feature and temporal control of DDR, we designed and synthesized polycarcin V-based bifunctional chemical probes, including one that cross-links DNA to DNA-binding protein to explore the DDR induced by polycarcin V and uncover novel DNA–protein interactions. Utilizing this chemical probe and activity-based protein profiling-stable isotope labeling with amino acids in cell culture, we identified 311 DNA-binding protein candidates, including known DDR factors and additional proteins that may be of interest in discovering new biology. We validated our approach by showing that our probe could specifically cross-link proteins involved in nucleotide excision repair (NER) that repair bulky DNA adducts. Our studies showed that the [2+2] cycloadduct formed by polycarcin V could indeed be repaired by NER in vivo . As a DNA-damaging agent, polycarcin V or its drug-like derivative plus blue light showed promising properties for psoriasis treatment, suggesting that it may itself hold promise for clinic applications. Abstract : Polycarcin V, a light-dependent DNA intercalating agent, shows promising therapeutic effects for psoriasis, and its light-activatable chemical probe derivative enabled the identification of 311 DNA-binding proteins which is significant for new biology discovery.